Will our cardiomyopathy patients accept gene therapy?

Neth Heart J. 2022 Jul;30(7-8):343-344. doi: 10.1007/s12471-022-01665-z. Epub 2022 Mar 2.

Abstract

Novel techniques such as gene therapy are becoming available in an attempt to cure inherited diseases. Before these new therapies can be offered to patients, we need to be aware of potential reservations or objections, not only from patients and their surroundings but also from the public. In addition, legal issues and costs need attention before curative gene therapy can be applied in the clinic. As this therapeutic approach is closer to becoming a reality, now is the right time to start the debate.

Keywords: Cardiomyopathy; Gene editing; Viral vectors.

Publication types

  • Review